1. Home
  2. LXRX vs CHN Comparison

LXRX vs CHN Comparison

Compare LXRX & CHN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LXRX
  • CHN
  • Stock Information
  • Founded
  • LXRX 1995
  • CHN 1992
  • Country
  • LXRX United States
  • CHN United States
  • Employees
  • LXRX N/A
  • CHN N/A
  • Industry
  • LXRX Biotechnology: Pharmaceutical Preparations
  • CHN Investment Managers
  • Sector
  • LXRX Health Care
  • CHN Finance
  • Exchange
  • LXRX Nasdaq
  • CHN Nasdaq
  • Market Cap
  • LXRX 124.4M
  • CHN 128.4M
  • IPO Year
  • LXRX 2000
  • CHN N/A
  • Fundamental
  • Price
  • LXRX $0.70
  • CHN $12.26
  • Analyst Decision
  • LXRX Buy
  • CHN
  • Analyst Count
  • LXRX 4
  • CHN 0
  • Target Price
  • LXRX $3.67
  • CHN N/A
  • AVG Volume (30 Days)
  • LXRX 5.7M
  • CHN 31.8K
  • Earning Date
  • LXRX 05-13-2025
  • CHN 01-01-0001
  • Dividend Yield
  • LXRX N/A
  • CHN 0.19%
  • EPS Growth
  • LXRX N/A
  • CHN N/A
  • EPS
  • LXRX N/A
  • CHN N/A
  • Revenue
  • LXRX $31,081,000.00
  • CHN N/A
  • Revenue This Year
  • LXRX N/A
  • CHN N/A
  • Revenue Next Year
  • LXRX $84.78
  • CHN N/A
  • P/E Ratio
  • LXRX N/A
  • CHN N/A
  • Revenue Growth
  • LXRX 2481.48
  • CHN N/A
  • 52 Week Low
  • LXRX $0.28
  • CHN $9.00
  • 52 Week High
  • LXRX $2.45
  • CHN $12.98
  • Technical
  • Relative Strength Index (RSI)
  • LXRX 60.07
  • CHN 52.61
  • Support Level
  • LXRX $0.63
  • CHN $12.00
  • Resistance Level
  • LXRX $0.71
  • CHN $12.51
  • Average True Range (ATR)
  • LXRX 0.07
  • CHN 0.33
  • MACD
  • LXRX -0.00
  • CHN 0.07
  • Stochastic Oscillator
  • LXRX 55.00
  • CHN 59.03

About LXRX Lexicon Pharmaceuticals Inc.

Lexicon Pharmaceuticals Inc is a biopharmaceutical company. It is engaged in the discovery, development, and commercialization of pharmaceutical products for the treatment of human diseases. Some of its drug candidates are LX9211, an orally-delivered small molecule drug candidate, as a treatment for neuropathic pain; and sotagliflozin, an orally-delivered small molecule drug candidate, as a treatment for heart failure and type 1 diabetes.

About CHN China Fund Inc. (The)

CHINA FUND INC is a non-diversified, closed-end management investment company. Its investment objective is a long-term capital appreciation which it seeks to achieve by investing in equity securities with trading in China and outside China. It invests in various industries such as Insurance, Entertainment, Machinery, Electrical Equipment, Beverages, Hotels, Restaurants, and Leisure among others.

Share on Social Networks: